`

Social Media Monitoring Page for Arqule

latest blog entries

Loading...

Branding...

latest headlines for company on cafepharma

Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR

Yahoo

Mon, 04/01/13 - 10:58 am

tags: akt protein inhibitor, ARQ092, Arqule, cancer, Daiichi Sankyo

ArQule Earnings: Everything You Must Know Now

Wall St. Cheat Sheet

Thu, 03/14/13 - 10:49 am

tags: Arqule, earnings

ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib

Yahoo/Fly on the Wall

Thu, 01/31/13 - 11:48 am

tags: Arqule, hepatocellular carcinoma, tivantinib

Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance

Seeking Alpha

Tue, 01/15/13 - 12:39 pm

tags: Arqule, colorectal cancer, Daiichi Sankyo, tivantinib

3 Horrendous Health-Care Stocks This Week

Motley Fool

Sat, 01/12/13 - 11:38 am

tags: Arqule, Idenix, Sequenom

Biotech Portfolio Update: 2012 Summary And 2013 Outlook

Seeking Alpha

Mon, 12/24/12 - 11:44 am

tags: Arqule, Array Biopharma, Aveo Pharmaceutical, Celldex, Curis, Exelixis, Genmab, Incyte, MorphoSys, Novartis, Seattle Genetics, YM BioSciences

ArQule: An Inexpensive And Well-Financed Oncology Opportunity

Seeking Alpha

Thu, 12/13/12 - 5:29 pm

tags: ARQ-087, Arqule, Daiichi Sankyo

3 Biotechs With Good FDA News

Motley Fool

Wed, 10/17/12 - 11:49 am

tags: Amarin, Arqule, FDA, Threshold Pharmaceuticals

ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?

Seeking Alpha

Fri, 10/12/12 - 12:17 pm

tags: Arqule, cabozantinib, Exelixis, non-small cell lung cancer, tivantinib

Weekend Recap: Biotech Madness

Seeking Alpha

Sun, 10/07/12 - 11:47 am

tags: Acadia, Aeterna Zentaris, Amarin, Arena Pharmaceuticals, Arqule, Sarepta Therapeutics, Synta Pharmaceuticals

ArQule stock plunges as lung cancer study shelved

Yahoo/AP

Tue, 10/02/12 - 11:25 am

tags: Arqule, Daiichi Sankyo, lung cancer, non-small cell lung cancer, tivantinib

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib

Motley Fool

Fri, 08/31/12 - 12:27 pm

tags: Arqule, Astellas, lung cancer, Roche, Tarceva, tivantinib

ArQule Shares Drop on Lung Cancer Drug Safety Concern

Minyanville

Wed, 08/29/12 - 12:17 pm

tags: Arqule, lung cancer, tivantinib

3 Innovative Biotech Stocks To Consider Today

Seeking Alpha

Mon, 08/13/12 - 1:36 pm

tags: Arqule, Bayer, Celgene, OncoSec, Onyx

Winners Of ASCO 2012

Seeking Alpha

Mon, 06/11/12 - 6:19 pm

tags: Arqule, Array Biopharma, ASCO, Astex, AstraZeneca, Bristol-Myers Squibb, Curis, Exelixis, GSK, Immunogen, Pfizer, Sanofi, Seattle Genetics, Synta

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3

Seeking Alpha

Mon, 05/28/12 - 11:21 am

tags: Arqule, ASCO, Aveo, Bristol-Myers Squibb, Cyclacel, Sunesis, Synta

22 Biopharma Stocks With Breakout Potential in 2012

Seeking Alpha

Tue, 05/22/12 - 11:25 am

ASCO '12 Abstract Dump: Cancer Stocks in Focus

TheStreet.com

Thu, 05/17/12 - 10:35 am

tags: Ariad Pharmaceuticals, Arqule, Array Biopharma, ASCO, Aveo, Exelixis, Oncothyreon, Onyx, Pharmacyclics, Seattle Genetics

Upcoming ASCO Meeting Could Move These Stocks

Seeking Alpha

Wed, 04/04/12 - 8:45 am

tags: Allos, Ariad Pharmaceuticals, Arqule, Array Biopharma, ASCO, Exelixis, ImmunoCellular Therapeutics

Cancer Cures: ASCO Stocks to Give Your Portfolio a Boost

Motley Fool

Sat, 03/24/12 - 11:30 am

tags: Ariad Pharmaceuticals, Arqule, Aveo Pharmaceutical, Celldex, JNJ

Last 30 twitter posts